Predictive Oncology Price to Sales Ratio 2010-2023 | POAI
Historical PS ratio values for Predictive Oncology (POAI) over the last 10 years. The current P/S ratio for Predictive Oncology as of April 26, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-26 | 1.51 | 3.40 | |
| 2023-12-31 | 3.29 | $0.44 | 7.41 |
| 2023-09-30 | 3.20 | $0.46 | 6.97 |
| 2023-06-30 | 4.86 | $0.40 | 12.21 |
| 2023-03-31 | 6.54 | $0.38 | 17.25 |
| 2022-12-31 | 6.13 | $0.41 | 14.81 |
| 2022-09-30 | 7.20 | $0.49 | 14.72 |
| 2022-06-30 | 8.20 | $0.47 | 17.50 |
| 2022-03-31 | 19.54 | $0.50 | 39.01 |
| 2021-12-31 | 19.04 | $0.56 | 34.06 |
| 2021-09-30 | 26.60 | $0.88 | 30.33 |
| 2021-06-30 | 26.20 | $1.42 | 18.44 |
| 2021-03-31 | 24.20 | $1.66 | 14.61 |
| 2020-12-31 | 14.65 | $2.72 | 5.39 |
| 2020-09-30 | 16.28 | $4.65 | 3.51 |
| 2020-06-30 | 32.80 | $7.33 | 4.48 |
| 2020-03-31 | 31.51 | $7.91 | 3.98 |
| 2019-12-31 | 52.20 | $9.94 | 5.25 |
| 2019-09-30 | 101.00 | $12.38 | 8.16 |
| 2019-06-30 | 149.50 | $14.03 | 10.66 |
| 2019-03-31 | 150.00 | $19.12 | 7.85 |
| 2018-12-31 | 123.82 | $23.11 | 5.36 |
| 2018-09-30 | 212.00 | $25.17 | 8.42 |
| 2018-06-30 | 226.00 | $25.09 | 9.01 |
| 2018-03-31 | 220.00 | $22.52 | 9.77 |
| 2017-12-31 | 202.00 | $20.71 | 9.76 |
| 2017-09-30 | 290.72 | $23.68 | 12.28 |
| 2017-06-30 | 294.00 | $26.90 | 10.93 |
| 2017-03-31 | 420.00 | $29.76 | 14.11 |
| 2016-12-31 | 560.00 | $51.25 | 10.93 |
| 2016-09-30 | 825.00 | $270.48 | 3.05 |
| 2016-06-30 | 762.50 | $369.62 | 2.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.006B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.762B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| Movano (MOVE) | United States | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |